Related Experiment Videos
[Behcet's disease therapy review]
A Vidaller Palacín1, J Robert Olalla, B Sanuy Jiménez
1Departamento de Medicina Interna, Unidad de Diagnóstico y Seguimiento de Inmunología Clínica y Alergias, Institut Universitari Dexeus, C/Calatrava, 83, 08017 Barcelona.
Anales De Medicina Interna (Madrid, Spain : 1984)
|January 14, 2003
Summary
Behçet's disease is a rare inflammatory disorder causing mouth sores, skin lesions, and eye inflammation. Treatment varies based on affected organs, ranging from topical therapies to aggressive immunosuppressants for severe cases.
Area of Science:
- Rheumatology
- Immunology
- Dermatology
Context:
- Behçet's disease is a multisystem inflammatory disorder of unknown etiology.
- It commonly manifests with recurrent oral ulcers, genital aphthae, uveitis, and skin lesions.
- However, diverse clinical presentations involving virtually any organ system, including CNS, joints, vasculature, and GI tract, are reported.
Purpose:
- To provide a comprehensive overview of Behçet's disease.
- To discuss the varied clinical manifestations.
- To outline the complex therapeutic strategies based on organ involvement.
Summary:
- Therapeutic approaches are tailored to the specific organs affected.
- Mild cases or complex aphthosis may respond to topical treatments, colchicine, or dapsone.
- Severe ocular or systemic manifestations necessitate aggressive therapies, often combining corticosteroids with immunosuppressive agents like cyclosporine, azathioprine, or cyclophosphamide.
Impact:
- Highlights the complexity of Behçet's disease management.
- Emphasizes the need for individualized treatment plans.
- Informs clinicians on the spectrum of therapeutic options for Behçet's disease patients.